Ving J. Lee

2.8k citations

45 papers · 2.2k indexed · 1 hit paper · h-index 21

Impact in

Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy

Papers in

Molecular Medicine 20
- Antibiotic Resistance in Bacteria 20
Pharmacology 13
- Antibiotics Pharmacokinetics and Efficacy 8
- Microbial Natural Products and Biosynthesis 4

Co-authors: Suzanne Chamberland Olga Lomovskaya Scott J. Hecker Kazuki Hoshino Roger Léger Hiroko Ishida Mark S. Warren Kiyoshi Nakayama
Journals: Bioorganic & Medicinal Chemistry Letters (10 papers)The Journal of Antibiotics (4 papers)Journal of Medicinal Chemistry (4 papers)Journal of the American Chemical Society (3 papers)Tetrahedron Letters (3 papers)
Partner nations: United States Japan Russia

In The Last Decade

Ving J. Lee

44 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy 2001 · 731 citations

Peers

Countries citing papers authored by Ving J. Lee

Since Specialization

Citations

This map shows the geographic impact of Ving J. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ving J. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ving J. Lee more than expected).

Fields of papers citing papers by Ving J. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ving J. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ving J. Lee. The network helps show where Ving J. Lee may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ving J. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ving J. Lee Line = papers co-authored together Ving J. Lee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inhibitors of Bacterial Efflux Pumps as Adjuvants in Antibacterial Therapy and Diagnostic Tools for Detection of Resistance by Efflux Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·Françoise Van Bambeke, Jean‐Marie Pagès, Ving J. Lee	2010	19
2	MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: Highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate Bioorganic & Medicinal Chemistry ·Ken‐ichi Yoshida, Kiyoshi Nakayama, Masami Ohtsuka, A Bogdanitch, Yoshihiro Yokomizo, Atsunobu Sakamoto, Makoto Takemura, Kazuki Hoshino, Wanderléia Elizabeth Brinckmann, Nobuyuki Moriwaki, Kenji Namba, Kumi Yoshida, W Chen, Jason Z. Zhang, Ving J. Lee, William J. Watkins	2007	108
3	MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: Carbon-substituted analogues at the C-2 position Bioorganic & Medicinal Chemistry ·Ken‐ichi Yoshida, Kiyoshi Nakayama, A Bogdanitch, Shozo Kobayashi, Masami Ohtsuka, Makoto Takemura, Kazuki Hoshino, Wanderléia Elizabeth Brinckmann, A. Degler, Ving J. Lee, William J. Watkins	2005	40
4	MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 4: Addressing the problem of poor stability due to photoisomerization of an acrylic acid moiety Bioorganic & Medicinal Chemistry Letters ·Kiyoshi Nakayama, A Bogdanitch, Masami Ohtsuka, Yoshihiro Yokomizo, Atsunobu Sakamoto, Haruko C. Kawato, Kenichi Yoshida, Toshiharu Ohta, Kazuki Hoshino, 正義根本, Didik Setiyawan, Hiroko Ishida, Aesop Cho, Monica H. Palme, Jason Z. Zhang, Ving J. Lee, William J. Watkins	2004	43
5	MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimization Bioorganic & Medicinal Chemistry Letters ·Kiyoshi Nakayama, Yohei Ishida, Masami Ohtsuka, Haruko C. Kawato, Ken‐ichi Yoshida, Yoshihiro Yokomizo, Shigeru Hosono, Toshiharu Ohta, Kazuki Hoshino, Hiroko Ishida, Kumi Yoshida, Thomas E. Renau, Roger Léger, Jason Z. Zhang, Ving J. Lee, William J. Watkins	2003	66
6	MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds Bioorganic & Medicinal Chemistry Letters ·Kiyoshi Nakayama, Yohei Ishida, Masami Ohtsuka, Haruko C. Kawato, Kenichi Yoshida, Yoshihiro Yokomizo, Toshiharu Ohta, Kazuki Hoshino, Tsuyoshi Otani, 白井伸一, Kumi Yoshida, Hiroko Ishida, Ving J. Lee, Thomas E. Renau, William J. Watkins	2003	48
7	Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa Bioorganic & Medicinal Chemistry Letters ·Thomas E. Renau, Roger Léger, Hans Heusmann, Eric M. Flamme, Michael Wang, Rose Yen, Hoshino Mamoru, David E. Griffith, Suzanne Chamberland, Michael N. Dudley, Ving J. Lee, Olga Lomovskaya, William J. Watkins, Toshiharu Ohta, Kiyoshi Nakayama, Yohei Ishida	2003	76
8	MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model Bioorganic & Medicinal Chemistry Letters ·Kiyoshi Nakayama, Haruko C. Kawato, Jun Watanabe, Masami Ohtsuka, Kenichi Yoshida, Yoshihiro Yokomizo, Atsunobu Sakamoto, A Bogdanitch, Toshiharu Ohta, Kazuki Hoshino, Kumi Yoshida, Hiroko Ishida, Aesop Cho, Monica H. Palme, Jason Z. Zhang, Ving J. Lee, William J. Watkins	2003	55
9	Synthetic dihydropacidamycin antibiotics Bioorganic & Medicinal Chemistry Letters ·Constantine G. Boojamra, Rémy C. Lemoine, Johanne Blais, محمد الغزاوي, HJ Wester, Adwait Sanikop, Suzanne Chamberland, Scott J. Hecker, Ving J. Lee	2003	28
10	Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa Bioorganic & Medicinal Chemistry Letters ·Thomas E. Renau, Roger Léger, Eric M. Flamme, Fardin Hashemzadeh, Byron Vinicio Salinas Salinas, Andrew Snustad, Olga Lomovskaya, Suzanne Chamberland, Ving J. Lee, Toshiharu Ohta, Kiyoshi Nakayama, Yohei Ishida	2001	50
11	Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy Antimicrobial Agents and Chemotherapy ·Olga Lomovskaya, Mark S. Warren, Angela Lee, Jorge L. Galazzo, 竜二南, May Lee, Johanne Blais, O. Aslanapa, Suzanne Chamberland, Shannel Thorpe, Roger Léger, Scott J. Hecker, W. J. Watkins, Kazuki Hoshino, Hiroko Ishida, Ving J. Lee Hit paper breakdown →	2001	731
12	Discovery of RWJ-54428 (MC-02,479), a New Cephalosporin Active Against Resistant Gram-positive Bacteria. The Journal of Antibiotics ·Scott J. Hecker, Tomasz Glinka, Aesop Cho, Devon K. Check, Mariam Baig, Suzanne Chamberland, David C. Griffith, Ving J. Lee	2000	16
13	What's new in the antibiotic pipeline Current Opinion in Microbiology ·Ving J. Lee, George H. Miller, Morimasa Yagisawa	1999	13
14	Antibiotic resistance versus small molecules, the chemical evolution Medicinal Research Reviews ·Ving J. Lee, Scott J. Hecker	1999	37
15	Inhibitors of Efflux Pumps in Pseudomonas aeruginosa Potentiate the Activity of the Fluoroquinolone Antibacterial Levofloxacin Journal of Medicinal Chemistry ·Thomas E. Renau, Roger Léger, Eric M. Flamme, Joan Sangalang, Fardin Hashemzadeh, Rose Yen, Byron Vinicio Salinas Salinas, David Griffith, Suzanne Chamberland, Olga Lomovskaya, Scott J. Hecker, Ving J. Lee, Toshiharu Ohta, Kiyoshi Nakayama	1999	219
16	"Glycylcyclines". 3. 9-Aminodoxycyclinecarboxamides Journal of Medicinal Chemistry ·Timothy C. Barden, Brian L. Buckwalter, Raymond T. Testa, Peter J. Petersen, Ving J. Lee	1994	21
17	N-Phosphoryl derivatives of bisantrene. Antitumor prodrugs with enhanced solubility and reduced potential for toxicity Journal of Medicinal Chemistry ·K. C. Murdock, Ving J. Lee, Letycia Silva Galhardi, Frederick E. Durr, G. Nicolau, Dela Aryansi	1993	6
18	A novel reagent for regioselective cleavage of 2,3-epoxyalcohols by fluoride - a synthesis of 3-fluoro-293-dideoxy-d-erythro-pentose. Tetrahedron Letters ·Antonia A. Nikitenko, Boris Arshava, Federica Barontini, Christopher N. Marshall, Ving J. Lee, Stanley A. Lang	1992	16
19	N-Azamonobactams. 1. The synthesis of some 3-substituted N-azamonobactam derivatives. The Journal of Antibiotics ·William V. Curran, and Sally Reynard, Ving J. Lee	1988	5
20	Synthesis of s‐triazines bearing three different substituents Journal of Heterocyclic Chemistry ·Yang‐I Lin, 美代子塩沢, Ving J. Lee, H. S. Kim	1982	10

About Ving J. Lee

Ving J. Lee is a scholar working on Molecular Medicine, Pharmacology, Toxicology, Organic Chemistry and Pharmaceutical Science, having authored 45 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (20 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Cancer therapeutics and mechanisms (7 papers), Chemical Synthesis and Analysis (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Microbial Natural Products and Biosynthesis (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Synthesis and Catalytic Reactions (3 papers). The work is most often cited by research in Molecular Medicine (1.4k citations), Pharmacology (687 citations), Applied Microbiology and Biotechnology (59 citations), Endocrinology (141 citations) and Microbiology (160 citations). Ving J. Lee has collaborated with scholars based in United States, Japan and Russia. Frequent co-authors include Suzanne Chamberland, Olga Lomovskaya, Scott J. Hecker, Kazuki Hoshino, Roger Léger, Hiroko Ishida, Mark S. Warren, Kiyoshi Nakayama, Johanne Blais and W. J. Watkins. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, The Journal of Antibiotics, Journal of Medicinal Chemistry, Journal of the American Chemical Society and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact